Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity
Peripheral neurotoxicity is the dose-limiting factor for clinical use of platinum derivatives, a class of anticancer drugs which includes cisplatin, carboplatin, and oxaliplatin. In particular cisplatin and oxaliplatin induce a severe peripheral neurotoxicity while carboplatin is less neurotoxic. Th...
Main Authors: | Alessia Chiorazzi, Sara Semperboni, Paola Marmiroli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Toxics |
Subjects: | |
Online Access: | http://www.mdpi.com/2305-6304/3/3/304 |
Similar Items
-
Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
by: Jelena S. Katanic Stankovic, et al.
Published: (2020-10-01) -
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats
by: Cristina Meregalli, et al.
Published: (2018-08-01) -
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
by: Andreas A. Argyriou
Published: (2015-05-01) -
Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01) -
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)